Literature DB >> 29214134

A Response to Papatola and Lustig's Paper on Navigating a Managed Care Peer Review: Guidance for Clinicians Using Applied Behavior Analysis in the Treatment of Children on the Autism Spectrum.

Julie Kornack1, Brandon Herscovitch2, Ashley L Williams2.   

Abstract

In their 2016 article, "Navigating a Managed Care Peer Review: Guidance for Clinicians Using Applied Behavior Analysis [ABA] in the Treatment of Children on the Autism Spectrum," Papatola and Lustig provide an overview of the managed care process, discuss the medical necessity of ABA, and offer guidance to clinicians on how to navigate the managed care peer review process. Given that the authors are employed by a large international health insurance carrier and conduct peer reviews on behalf of that organization, this response seeks to provide guidance from both the clinical and public policy perspectives that reflect best practices in the field of autism treatment. This response is not written with the intention of providing or replacing legal advice; rather, this paper offers health care providers of ABA an essential understanding of some of the laws that govern and support their efforts to secure medically necessary treatment and the mechanisms in place with which to challenge decisions by managed care organizations, health plans, and health insurance issuers that may be contrary to best practices. Finally, suggestions are offered on how to navigate a peer review to ensure optimal outcomes and, when necessary, to lay the groundwork to overturn a funding source decision that does not reflect best practices or the standard of care in ABA-based autism treatment.

Entities:  

Keywords:  Applied behavior analysis; Autism; Fail first; Managed care; Mental health parity; Peer review

Year:  2017        PMID: 29214134      PMCID: PMC5711742          DOI: 10.1007/s40617-017-0192-x

Source DB:  PubMed          Journal:  Behav Anal Pract        ISSN: 1998-1929


  12 in total

1.  Age and IQ at intake as predictors of placement for young children with autism: a four- to six-year follow-up.

Authors:  S L Harris; J S Handleman
Journal:  J Autism Dev Disord       Date:  2000-04

2.  Progress and outcomes for children with autism receiving parent-managed intensive interventions.

Authors:  Peter Bibby; Svein Eikeseth; Neil T Martin; Oliver C Mudford; David Reeves
Journal:  Res Dev Disabil       Date:  2002 Jan-Feb

3.  Medical futility, medical necessity. The-problem-without-a-name.

Authors:  D Callahan
Journal:  Hastings Cent Rep       Date:  1991 Jul-Aug       Impact factor: 2.683

4.  Medical necessity: do we need it?

Authors:  L A Bergthold
Journal:  Health Aff (Millwood)       Date:  1995       Impact factor: 6.301

5.  Toward a functional analysis of self-injury.

Authors:  B A Iwata; M F Dorsey; K J Slifer; K E Bauman; G S Richman
Journal:  J Appl Behav Anal       Date:  1994

6.  Innovations in Behavioral Intervention Preparation for Paraprofessionals Working with Children with Autism Spectrum Disorder.

Authors:  Richard W Serna; Harold E Lobo; Cindy K Fleming; Richard K Fleming; Carol Curtin; Michelle M Foran; Charles D Hamad
Journal:  J Spec Educ Technol       Date:  2015-03

7.  Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2014-03-28

8.  Navigating a Managed Care Peer Review: Guidance for Clinicians Using Applied Behavior Analysis in the Treatment of Children on the Autism Spectrum.

Authors:  Kathleen J Papatola; Stuart L Lustig
Journal:  Behav Anal Pract       Date:  2016-04-01

Review 9.  Management of children with autism spectrum disorders.

Authors:  Scott M Myers; Chris Plauché Johnson
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

Review 10.  Parent inclusion in early intensive behavior interventions for young children with ASD: a synthesis of meta-analyses from 2009 to 2011.

Authors:  K Strauss; F Mancini; L Fava
Journal:  Res Dev Disabil       Date:  2013-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.